News
A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...
Ongoing research is needed to fully understand their risks, especially for long-term and higher-dose users. However, many ...
A New Zealand bariatric surgeon cautions that Wegovy, a new weight-loss drug, isn't a magic bullet for obesity. While it can trigger initial weight loss, long-term success hinges on lifestyle changes ...
A Wellington man is stoked to finally get his hands back on the weight loss drug he said changed his life. Wegovy was approved for weight loss in March 2025 with a doctor’s prescription. The drug ...
As weight loss jabs like Ozempic become ever more popular, doctors are growing increasingly concerned about their gnarly side ...
9h
The Sunday Guardian Live on MSNTo Ozempic or to Mounjaro? The weight loss drug primerIndia's top endocrinologist, Dr Ambrish Mithal has come out with a very well timed and a much needed explainer on the new crop of weight loss drugs that have flooded the market. Entitled, "The Weight ...
New Delhi: Drug major Cipla is preparing to foray into the weight management segment in India, its MD and global CEO Umang ...
A long-term investor in Apple (AAPL) might be perfectly thrilled at the stock's performance. It has returned 663% over the past 10 years, compared with a return of 261% for the S&P 500 SPX. And ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results